Filetype
The Translational Cancer Faster Forward doctoral/postdoctoral programmes (2018-2025). The CanFaster programme is supported by the European Union’s Marie Skłodowska-Curie COFUND programme (Horizon 2020 framework) based on the "Mobility across borders" philosophy. The CanFaster programme has attracted international PhD and Postdoc fellows (ER) with an interest in applied medical research in oncology
https://www.createhealth.lth.se/canfaster - 2025-10-23
The links below open on the respective publication website.In vivo dendritic cell reprogramming for cancer immunotherapy.Authors: Ascic, E., Catena, X., et al.Publication: Science 386, 6719Year: 2024Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab.Authors: Meng, P., Dalal, H., Chen, Y., Brueffer, C., Gladchuk, S., Alcaide, M., ... &
https://www.createhealth.lth.se/canfaster/publications - 2025-10-23
Inducing anti-tumor immunity with in-situ direct reprograming of cancer cells to cDC1sNext generation immuno-oncological targets for cancer therapySubtype-dependent biomarkers for systemic therapy in bladder cancer
https://www.createhealth.lth.se/canfaster/ongoing-canfaster-postdoc-projects - 2025-10-23
Immunotherapy has transformed the cancer treatment landscape leading to long-term responses. However, these strategies are effective in a limited number of patients and often lose their efficacy as the tumor progresses. Insufficient antigen presentation mediated by MHC downregulation and exclusion of functional antigen-presenting cells (APCs) from the tumor microenvironment (TME) are critical evas
Immuno-oncological (I-O) treatment methods have revolutionized cancer therapy and tremendous clinical benefits are achieved in some cancer patients. However, today a limited number of I-O drug targets are used and only a fraction of all cancer patients has a therapeutic response. We need to further understand the immune system in cancer in order to develop novel treatment strategies and improve su
Cancer in the urinary bladder afflicts around 3000 persons per year in Sweden, most often older men and smokers. Despite being a quite common cancer type it is an understudied cancer type considering the burden to society and health outcomes [1].To patients with superficial cancer limited to the mucosa of the urinary bladder, the prognosis is good, but once the tumor has grown into the muscle-laye
Address Medicon Village - Building 406Sheelevägen 2 223 81 LundSweden Are you applying for a position? For general questions regarding the call, contact us at:canfaster-postdoc [at] immun [dot] lth [dot] se (canfaster-postdoc[at]immun[dot]lth[dot]se) DirectorSara Ek, Professorsara [dot] ek [at] immun [dot] lth [dot] se (sara[dot]ek[at]immun[dot]lth[dot]se)+46-46-222-3824 Research coordinatorJana H
https://www.createhealth.lth.se/canfaster/contact - 2025-10-23
Please wait... Address Medicon VillageBuilding 406Scheelevägen 2 223 81 LundSweden
https://www.createhealth.lth.se/contact - 2025-10-23
Our approach is translational - It starts from a specific need, identified by our clinical partners. We use novel technological approaches to find the relevant solutions, which can be implemented into the clinic with much shorter lead times. CREATE Health, inaugurated in 2006 with a focus on precision medicine, is a strategic centre for translational research focusing on the early diagnosis and pr
https://www.createhealth.lth.se/about - 2025-10-23
Promising results for Lead Biologics’ first-in-class checkpoint inhibitor published in Nature Cancer Lead Biologics takes a major step towards a new cancer treatment. A new study shows that the company’s drug candidate effectively inhibits a previously unknown immune escape mechanism and eliminates acute myeloid leukemia cells in advanced experimental models.– This confirms the great interest in
https://www.createhealth.lth.se/news-0 - 2025-10-23
Focus AreasPsychological Resilience in Cancer, Bioinformatics and AIOngoing Collaborations and partnersCantargia, IMMUNOVIA, Paindrainer, Akuru PharmaSpin OutsWorking together is an integral part of CREATE Health’s DNA
https://www.createhealth.lth.se/research-and-innovation - 2025-10-23
CREATE Health has been a leader in developing novel therapeutic and diagnostic innovations, which have been further developed in a commercial setting in a start-up company. Immuno-OncologyImmuno-oncology has provided a number of very exciting clinical improvements, by focussing on how the immune system regulates tumor eradication. This has been achieved by the discovery and functional implementati
https://www.createhealth.lth.se/research-and-innovation/focus-areas - 2025-10-23
In 2025, CREATE Health Translational Cancer Center received a donation from the Mrs Berta Kamprad’s Cancer Foundation of 420 million SEK. This is the single largest donation to Lund University, since its founding in 1666. The funds are distributed over a five-year period and dedicated to translational cancer research within the L2CancerBridge program.Other previous and current funding for the CREA
https://www.createhealth.lth.se/about/funding - 2025-10-23
When conducting a risk assessment for laboratory work or experiments, it is crucial to carefully consider the potential consequences of water outages. Having a well-defined plan of action is essential to mitigate risks effectively. Risk assessment: Evaluate the potential consequences of water outages. Consider the impact on critical processes, safety and experiments.Particularly critical operation
https://www.kc.lu.se/en/employee/general-safety-regulations/9-plans-action/92-plan-action-water-outage - 2025-10-23
When the evacuation alarm sounds, immediately follow these steps:Interrupt work in a safe and secure manner.Ventilation hood procedures: Interrupt work in ventilation hoods in a way that ensures safety even for an extended time. Then close the hood.Check rooms: In each room, verify that no one is left behind. Close the door when leaving.Bring personal items: If possible, without delaying evacuatio
https://www.kc.lu.se/en/employee/general-safety-regulations/9-plans-action/93-plan-action-emergency-evacuations - 2025-10-23
The general rules for work at Kemicentrum are regulated by several different laws and legislations. A selection of different legislation is presented below. The official language is Swedish. Swedish Work Environment Authority's regulations (in Swedish: AFS)On January 1, 2025, these regulations will be replaced by new regulations in a revised structure although the rules will largely remain the sam
https://www.kc.lu.se/en/employee/general-safety-regulations/10-legislation - 2025-10-23
Lund University has a central Health and Safety Committee and 28 primary work environment areas. Among these, Kemicentrum is one. Kemicentrum comprises the following two departments:Department of ChemistryDepartment of Process and Life Science EngineeringWork environment areas and responsibilitiesFrom a work environment safety perspective, the divisions within the Department of Process and Life Sc
https://www.kc.lu.se/en/employee/general-safety-regulations/11-organization - 2025-10-23
Reassembly point 1: Building 1 westCASChemical Engineering Students and teaching staff in the lecture halls and course laboratory Building 3Biotechnology and Applied MicrobiologyCaretakersChemical EngineeringPhysical ChemistryService groupComputational ChemistryCR Building 5:The hallBiotechnology (Course lab)Electron Microscopy, n-CHREMFood and PharmaReassembly point 2: Building 1 east:Administr
https://www.kc.lu.se/en/employee/general-safety-regulations/12-reassembly-points - 2025-10-23
Lidman, U. (2008) Toxikologi - Läran om gifter. Lund: Studentlitteratur. ISBN 978-91-44-01965-9Lunn, G. & Sansone, E. B. (2012) Destruction of Hazardous Chemicals in the Laboratory. (3rd ed.) Hoboken: Wiley-Blackwell. ISBN 978-0-470-48755-6Slätt, J, & Janosik, T. (2012) Laboratoriesäkerhet: En grundläggande handbok för kemilaboratoriet. Lund: Studentlitteratur. ISBN 978-91-44-08125-0Sterner, O. (2
https://www.kc.lu.se/en/employee/general-safety-regulations/13-bibliography - 2025-10-23
At Kemicentrum, all chemistry subjects within Lund University's Faculty of Engineering, LTH and the Faculty of Science come together. With over 1,000 employees and students, we are the largest center for education and research in chemistry in Scandinavia. Departments at Kemicentrum At Kemicentrum, research and education in chemistry are conducted at two departments; the Department of Chemistry and
https://www.kc.lu.se/en/about-kemicentrum-0 - 2025-10-23
